Telemetry Investments, L.L.C. Paratek Pharmaceuticals, Inc. Transaction History
Telemetry Investments, L.L.C.
- $63.3 Million
- Q4 2022
A detailed history of Telemetry Investments, L.L.C. transactions in Paratek Pharmaceuticals, Inc. stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 483,000 shares of PRTK stock, worth $0. This represents 1.43% of its overall portfolio holdings.
Number of Shares
483,000
Previous 345,000
40.0%
Holding current value
$0
Previous $887,000
1.8%
% of portfolio
1.43%
Previous 1.14%
Shares
15 transactions
Others Institutions Holding PRTK
# of Institutions
4Shares Held
1.54MCall Options Held
0Put Options Held
0About Paratek Pharmaceuticals, Inc.
- Ticker PRTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,862,500
- Description
- Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...